A - Agilent Technologies, Inc.
| Previous Close | 66.910 |
| Open | 66.680 |
| Bid | 66.240 x 700 |
| Ask | 66.250 x 500 |
| Day's Range | 65.990 - 66.610 |
| 52 Week Range | 42.920 - 67.820 |
| Volume | 1,197,082 |
| Avg. Volume | 1,599,947 |
| Market Cap | 21.32B |
| Beta | 1.58 |
| PE Ratio (TTM) | 34.16 |
| EPS (TTM) | 1.94 |
| Earnings Date | Nov 13, 2017 - Nov 17, 2017 |
| Dividend & Yield | 0.53 (0.79%) |
| Ex-Dividend Date | 2017-10-02 |
| 1y Target Est | 71.31 |
- CNBC Videos•27 days ago
These high-flying life sciences stocks make Netflix and A...
It's a dream growth-investor sector but valuations are at the very high end of the stocks' own historical range.
- Yahoo Finance Contributors•9 days ago
5 Trade Ideas for Monday: Agilent Technologies, Commerce Bancshares, Palo Alto Networks, Pfizer & Timken
Capital Cube•6 hours agoAgilent Technologies, Inc. : A-US: Dividend Analysis : October 03rd, 2017 (record date) : By the numbers : October 17, 2017
Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing Agilent Technologies, Inc. with the following peers – PerkinElmer, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Teradyne, Inc., National Instruments Corporation, Illumina, Inc., AMETEK, Inc., Bruker Corporation, General Electric Company and Spirent Communications plc Sponsored ADR (PKI-US, TMO-US, DHR-US, TER-US, NATI-US, ILMN-US, AME-US, BRKR-US, GE-US ... Read more (Read more...)
- Business Wire•7 hours ago
Agilent Expands SureGuide Portfolio with CRISPR-based Products to Accelerate Disease Research
Agilent Technologies Inc. today announced the first expansion of the SureGuide pooled CRISPR libraries for functional genomics, offering pooled libraries for CRISPR activation and interference .
- Capital Cube•4 days ago
ETFs with exposure to Agilent Technologies, Inc. : October 13, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Agilent Technologies, Inc. Here are 5 ETFs with the largest exposure to A-US. Comparing the performance and risk of Agilent Technologies, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
- Zacks•6 days ago
Why You Should Add Agilent (A) to Your Portfolio Right Now
Agilent Technologies (A) continues to perform well, driven by differentiated products, new technologies, increased focus on segments and innovation strategy.
- Zacks•6 days ago
Will Agilent Technologies (A) Crush Estimates at Its Next Earnings Report?
Agilent Technologies (A) has seen a nice short-term history of beating earnings estimates, and looks poised to crush analyst expectations in its next earnings report as well.
Markit•8 days agoSee what the IHS Markit Score report has to say about Agilent Technologies Inc.
Agilent Technologies Inc NYSE:A
- Capital Cube•18 days ago
ETFs with exposure to Agilent Technologies, Inc. : September 29, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Agilent Technologies, Inc. Here are 5 ETFs with the largest exposure to A-US. Comparing the performance and risk of Agilent Technologies, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
- Zacks•20 days ago
Agilent Boosts Market Share With FDA Nod to New Cancer Test
Agilent Technologies' (A) recent FDA approval for a cancer diagnostic, PD-L1 IHC 28-8 pharmDx for UC and SCCHN patients will further expand its share in the growing cancer-diagnostic market.
Markit•20 days agoSee what the IHS Markit Score report has to say about Agilent Technologies Inc.
Agilent Technologies Inc NYSE:A
- GuruFocus.com•21 days ago
Beating the Benchmark: American Airlines, Apple
Stocks that outperformed the S&P 500 over the past year
Markit•21 days agoSee what the IHS Markit Score report has to say about Agilent Technologies Inc.
Agilent Technologies Inc NYSE:A
Markit•22 days agoSee what the IHS Markit Score report has to say about Agilent Technologies Inc.
Agilent Technologies Inc NYSE:A
- Harvest Exchange•23 days ago
Drivers of commodities in the medium term - global growth and dollar - look positive
If you wanted to focus on three longer-term macro factors that will drive overall commodity prices, it will be global growth, the dollar, and liquidity. The determination of long-only allocations in any asset allocation should focus on these three. ...
- Business Wire•25 days ago
CORRECTING and REPLACING Agilent Technologies Receives Expanded FDA Approval for the Use of Dako PD-L1 IHC 22C3 pharmDx Companion Diagnostic in Gastric or Gastroesophageal Junction (GEJ) Cancer
Third paragraph of release should read: The expanded approvals for PD-L1 IHC 22C3 pharmDx and KEYTRUDA means that these patients now have the possibility of receiving a targeted anti-PD-1 immunotherapy .
Markit•25 days agoSee what the IHS Markit Score report has to say about Agilent Technologies Inc.
Agilent Technologies Inc NYSE:A
- Business Wire•27 days ago
Agilent Technologies Announces Cash Dividend of 13.2 Cents per Share
Agilent Technologies Inc. today announced that a quarterly dividend of 13.2 cents per share of common stock will be paid on October 25, 2017, to all shareholders of record as of the close of business on October 3, 2017.
- Market Realist•27 days ago
Agilent Technologies’ Downward Sloping Dividend Yield Curve
Agilent Technologies’ net revenue rose 6.0% in the first nine months of 2017, driven by every segment. Income from operations rose 41.0% as total costs didn't increase much.
Markit•27 days agoSee what the IHS Markit Score report has to say about Agilent Technologies Inc.
Agilent Technologies Inc NYSE:A
- Business Wire•28 days ago
Agilent Technologies Joins with LabCentral to Help Advance Scientific Discovery
Agilent Technologies Inc. has announced a platinum sponsorship agreement with LabCentral, a biotech innovation hub based in Cambridge, Massachusetts. LabCentral is an independent, shared laboratory space designed as a launchpad for high-potential life sciences and biotech startups.
- Business Wire•28 days ago
Agilent Announces Expanded Use of Cancer Diagnostic in the United States
Agilent Technologies Inc. today announced that the U.S. Food and Drug Administration has approved the cancer diagnostic known as PD-L1 IHC 28-8 pharmDx for use in cases of urothelial carcinoma and of squamous cell carcinoma of the head and neck .
- Zacks•last month
Agilent Technologies (A) Up 10.6% Since Earnings Report: Can It Continue?
Agilent Technologies (A) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks•last month
How Agilent Technologies (A) Stock Stands Out in a Strong Industry
Agilent Technologies (A) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
- Capital Cube•last month
ETFs with exposure to Agilent Technologies, Inc. : September 13, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Agilent Technologies, Inc. Here are 5 ETFs with the largest exposure to A-US. Comparing the performance and risk of Agilent Technologies, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
